| Abstrakt: |
Researchers at University Malaysia Sabah have conducted a study on immune-related adverse reactions in pulmonary carcinoma, highlighting the importance of understanding these side effects in immunotherapy treatment. The study analyzed 124 publications from 1991 to 2023, showing a significant increase in research activity post-2015, with China and the USA contributing over 50% of the studies. The research suggests future investigations into the pulmonary microbiota and tumor microenvironment to improve treatment efficacy and patient outcomes. [Extracted from the article] |
